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The N-terminal domain of nucleocapsid protein from human coronavirus OC43
(HCoV-OC43 N-NTD) mostly contains positively charged residues and has
been identified as being responsible for RNA binding during ribonucleocapsid
formation in the coronavirus. In this study, the crystallization and preliminary
crystallographic analysis of HCoV-OC43 N-NTD (amino acids 58–195) with a
molecular weight of 20 kDa are reported. HCoV-OC43 N-NTD was crystallized
at 293 K using PEG 1500 as a precipitant and a 99.9% complete native data set
was collected to 1.7 A˚ resolution at 100 K with an overall Rmerge of 5.0%. The
crystals belonged to the hexagonal space group P65, with unit-cell parameters
a = 81.57, c = 42.87 A˚. Solvent-content calculations suggest that there is likely to
be one subunit of N-NTD in the asymmetric unit.
1. Introduction
Human coronavirus OC43 (HCoV-OC43) is responsible for approxi-
mately 20% of all colds (Kaye et al., 1971; Lai & Cavanagh, 1997).
Although HCoV-OC43 infections are generally mild, more severe
upper and lower respiratory-tract infections such as bronchiolitis and
pneumonia have been characterized, especially in infants, elderly
individuals and immunocompromised patients (El-Sahly et al., 2000;
Gagneur et al., 2002; St-Jean et al., 2004). According to serological
cross-reactivity, HCoV-OC43 is a representative of the class II
coronaviruses. The RNA genomes of coronaviruses comprise of
several genes that encode several structural and nonstructural
proteins and are arranged in the order 50-pol (polymerase)–S (spike)–
E (envelope)–M (matrix)–N (nucleocapsid)-30 (Navas-Martin &
Weiss, 2004). The virion envelope surrounding the nucleocapsid
contains the structural proteins S, M, E and N. Some of them contain
a third glycoprotein, HE (haemagglutinin-esterase), which is present
in most class II coronaviruses. The primary function of the HCoV N
protein is to recognize a stretch of RNA that serves as a packaging
signal and leads to the formation of the ribonucleoprotein (RNP)
complex during assembly (Lai & Cavanagh, 1997). RNP may be
important in keeping the RNA in an ordered conformation suitable
for replication and transcription of the viral genome (Lai, 2003;
Nelson et al., 2000; Huang et al., 2004; Navas-Martin & Weiss, 2004).
In addition, the N protein is also an important diagnostic marker and
is the most immunodominant antigen in infected hosts (Chan et al.,
2005; Woo et al., 2004).
The N protein of HCoV-OC43 has a molecular weight of 49.5 kDa
and a pI of 10.0 and is a highly basic protein with a high hydrophilicity
(Hogue & Brian, 1986; Pohl-Koppe et al., 1995). We have previously
shown that the N-terminal domain of HCoV-OC43 (N-NTD) con-
tains most of the positively charged residues that are responsible for
RNA binding, while the C-terminal domain (N-CTD) mainly acts
as an oligomerization module to form a capsid (Huang et al., 2009;
Saikatendu et al., 2007; Jayaram et al., 2006; Fan et al., 2005). The
central disordered region of the N protein has also been shown to
contain an RNA-binding region (Chang et al., 2009). In order to
clarify the mechanism by which the N protein of HCoV-OC43 binds
to nucleic acids, we have undertaken the determination of the crystal
structure of the N-terminal domain of HCoV-OC43 (residues
58–195).
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2. Experimental methods
2.1. Expression and purification of HCoV-OC43 N-NTD
The templates for the HCoV-OC43 N protein were kindly provided
by the Institute of Biological Chemistry, Academia Sinica (Taipei,
Taiwan). In order to generate a truncated form of the recombinant
HCoV-OC43 N-NTD, the gene encoding the N protein was amplified
by the polymerase chain reaction (PCR) using Pfu polymerase with
the forward primer 50-CGCTATGAATTCAATGTTGTACCCTAC-
TATTCTTGGTTC-30 and the reverse primer 50-ACAACGCTCGA-
GAGCAGACCTTCCTGAGCCTTCAATAT-30. The PCR products
were digested with EcoRI and XhoI and the resulting DNA frag-
ments were cloned into pET28a (Novagen) using T4 ligase (NEB).
The recombinant plasmid was transformed into Escherichia coli
BL21-RIL using the heat-shock method. The cells were grown at
310 K in Luria–Bertani medium containing 50 mg l1 kanamycin.
Protein expression was induced at an OD600 of 0.6 by the addition of
1 mM isopropyl -d-1-thiogalactopyranoside (IPTG) at 283 K for
24 h. The expressed N-NTD contains N-terminal (MGSSHHHHH-
HSSGLVPRGSHMASMTGGQQMGRGSEF) and C-terminal (LE-
HHHHHH) tags. After harvesting the bacteria by centrifugation
(6000 rev min1, 30 min, 277 K), the bacterial pellets were resus-
pended in sonication buffer (50 mM Tris-buffered solution pH 7.5,
150 mM NaCl and 15 mM imidazole) and lysed by sonication for
30 min (3 s pulse on and 6 s pulse off). Soluble proteins were obtained
from the supernatant by centrifugation (13 000 rev min1, 30 min,
277 K). N-NTD carrying His6 tags at the N-terminus and C-terminus
was purified using an Ni–NTA column (Novagen) with an elution
gradient from 15 to 250 mM imidazole in buffer solution (50 mM Tris-
buffered solution pH 7.5 and 150 mM NaCl). Fractions containing
N-NTD were pooled and collected at 250 mM imidazole and dialyzed
against 50 mM Tris-buffered solution pH 7.5 containing 150 mM
NaCl (Fig. 1). The purified N-NTD was concentrated to 8 mg ml1 in
50 mM Tris–HCl pH 7.5 containing 255 mM NaCl prior to crystal-
lization.
2.2. Crystallization
Initial crystallization experiments were set up using the Qiagen
JCSG+ Suite and PACT Suite crystal screens (Newman, 2005) using
the sitting-drop vapour-diffusion method in accordance with our
previously described protocol (Chou & Hou, 2008). Each of the
crystallization conditions (2 ml) from the screening kits was mixed
with 1.5 ml purified protein solution (8 mg ml1) and 0.5 ml 40%
hexanediol at room temperature (298 K) and equilibrated against
400 ml solution in the well of a Cryschem plate. The conditions were
refined over seven cycles and crystals were grown in solution con-
taining 0.25M succinic acid–phosphate–glycine (SPG) buffer pH 6.0,
25% PEG 1500 equilibrated at 293 K against 400 ml precipitation
solution. The SPG buffer was prepared by mixing succinic acid
(Sigma), sodium dihydrogen phosphate (Merck) and glycine (Merck)
in a 2:7:7 molar ratio and was adjusted to pH 6.0 with sodium
hydroxide (Newman, 2004). The crystals appeared within two weeks
and the largest crystal grew to dimensions of approximately 200 
100  100 mm (Fig. 2).
2.3. X-ray data collection and processing
Crystals were soaked in reservoir solution containing 30%(v/v)
glycerol as a cryoprotectant prior to flash-cooling in a nitrogen-gas
stream at 100 K. High-resolution X-ray data were collected using a
synchrotron-radiation source. A preliminary diffraction image was
obtained on NSRRC (National Synchrotron Radiation Research
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Figure 1
SDS–PAGE analysis of HCoV-OC43 N-NTD stained with Coomassie Brilliant
Blue. LaneM, protein markers (kDa); lane 1, purified HCoV-OC43 N-NTD; lane 2,
concentrated HCoV-OC43 N-NTD after dialysis.
Figure 2
Crystals of HCoV-OC43 N-NTD obtained with 25% PEG 1500 as a precipitant at
pH 6.0 by the sitting-drop vapour-diffusion method. The approximate dimensions
of the crystal are 200  100  100 mm.
Table 1
Data-collection statistics for HCoV-OC43 N-NTD crystals.
Values in parentheses are for the highest resolution shell.
X-ray source BL13B1, NSRRC
Wavelength (A˚) 1.0
Space group P65
Unit-cell parameters (A˚) a = 81.57, c = 42.87
Resolution limits (A˚) 30–1.70 (1.76–1.70)
Total reflections 149206
Unique reflections 18040
Completeness (%) 99.9 (99.9)
Redundancy 8.3 (7.7)
Rmerge† (%) 5.0 (76.1)
hI/(I)i 27.8 (2.46)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ.
Center, Hsinchu, Taiwan) contract beamline BL12B2 at SPring-8
(Hyogo, Japan) using an ADSC Q210r detector. The complete data
set was collected on beamline BL13B1 at NSRRC using an ADSC
Q315r detector. The crystal-to-detector distance was 150 mm. The
oscillation width and exposure time for each frame were 1 and 10 s,
respectively. Crystallographic data integration and reduction were
performed using the HKL-2000 program package (Otwinowski &
Minor, 1997). The crystallographic statistics of data collection for
N-NTD are listed in Table 1.
3. Results and discussion
The HCoV-OC43 N-NTD crystal chosen for this study was shown to
diffract X-rays to 1.7 A˚ resolution (Fig. 3) and belonged to space
group P65, with unit-cell parameters a = 81.57, c = 42.87 A˚. The
Matthews coefficient of 2.06 A˚3 Da1 calculated usingMATTHEWS_
COEF (Collaborative Computational Project, Number 4, 1994;
Matthews, 1968) suggested there was likely to be one molecule in the
asymmetric unit, with a solvent content of 40.26%. A homology
search for the HCoV-OC43 N-NTD structure was performed using
the BLAST server (Altschul et al., 1997; http://blast.ncbi.nlm.nih.gov/
Blast.cgi) when the synchrotron data were collected in December
2008. The sequence-alignment search indicated that HCoV-OC43
N-NTD shares 30–40% sequence identity with other N-NTDs of
coronaviruses (Fig. 4) and the N-terminal domain from SARS
coronavirus (PDB code 2ofz; Saikatendu et al., 2007) was chosen as
an initial search model owing to the lowE value of 1 1023. The first
molecular-replacement trial was performed using the automated
interface PERON at the Protein Tectonics Platform (PTP), RIKEN
SPring-8 Center, Japan (Sugahara et al., 2008). The best result was
obtained using theMOLREP program (Vagin & Teplyakov, 2010). A
single and unambiguous solution for the rotation and translation
function was obtained with reflections in the resolution range 30–
3.0 A˚, and yielded a final correlation coefficient of 0.79 and an R
factor of 0.44. The core of the model consists of a tightly packed
-sheet of five antiparallel strands surrounded by large loops.
Structural refinement of the HCoV-OC43 N-NTD is currently in
progress.
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